➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
McKinsey
Merck
Mallinckrodt
Johnson and Johnson

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE


Email this page to a colleague

« Back to Dashboard

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Gilead Sciences ATRIPLA efavirenz; emtricitabine; tenofovir disoproxil fumarate TABLET;ORAL 021937 NDA Gilead Sciences, LLC 15584-0101-1 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (15584-0101-1) 2006-07-20
Gilead Sciences ATRIPLA efavirenz; emtricitabine; tenofovir disoproxil fumarate TABLET;ORAL 021937 NDA REMEDYREPACK INC. 70518-0341-0 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-0341-0) 2017-03-20
Aurobindo Pharma Ltd EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE efavirenz; emtricitabine; tenofovir disoproxil fumarate TABLET;ORAL 203041 ANDA Aurobindo Pharma Limited 65862-497-30 30 TABLET, FILM COATED in 1 BOTTLE (65862-497-30) 2021-03-10
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Boehringer Ingelheim
Baxter
Colorcon
McKinsey